PTC Therapeutics CEO Stuart Peltz's 2021 pay rises 4% to $11M
PTC Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 28, 2022
PTC Therapeutics reported fiscal year 2021 executive compensation information on April 28, 2022.
In 2021, five executives at PTC Therapeutics received on average a compensation package of $5.7M, a 12% increase compared to previous year.
Average pay of disclosed executives at PTC Therapeutics
Stuart W. Peltz, Chief Executive Officer, received $11M in total, which increased by 4% compared to 2020. 69% of Peltz's compensation, or $7.6M, was in option awards. Peltz also received $835K in non-equity incentive plan, $769K in salary, $1.8M in stock awards, as well as $32K in other compensation.
Emily Hill, Chief Financial Officer, received a compensation package of $4.5M, which increased by 22% compared to previous year. 66% of the compensation package, or $3M, was in option awards.
Mark E. Boulding, Chief Legal Officer, earned $4.3M in 2021, a 21% increase compared to previous year.
Neil Almstead, Chief Technical Operations Officer, received $4.3M in 2021, which increases by 10% compared to 2020.
Eric Pauwels, Chief Business Officer, earned $4.3M in 2021, a 3% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 28, 2022.